Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Grail

- PMLiVE

NICE backs expanded use of Brilique in final guidance

AZ’s maintenance therapy recommended for long-term use, post-heart attack

- PMLiVE

NICE backs Eisai’s Halaven for breast cancer

Reverses 2012 rejection due to new data and patient access discount

- PMLiVE

NICE set to reject Merck’s Erbitux for head and neck cancer

Draft guidance rules the treatment does not provide value for money

Communicating with payers to improve patient access

A transforming NHS brings with it many opportunities. Working with payers to put patients at the heart of everything while reducing costs is fundamental to success.

- PMLiVE

UK to cut wait to innovative treatments by four years

Proposals in the Accelerated Access Review aim to speed up access to innovation

- PMLiVE

NHS marks its Twitter debut with story-sharing initiative

Three-month project will see a patient or staff member take over the new account

- PMLiVE

Regional NHS pulmonary rehabilitation video campaign launched

Aims to boost referral rates among GPs in the north east of England

- PMLiVE

The UK’s new Cancer Drugs Fund

"Clearer, faster decision-making" promised

UK to establish a digital academy for healthcare professionals

NHS technology plans will also see 12 trusts act as digitisation pioneers

- PMLiVE

NHS promotes person-centred care in new dementia film

Highlights the importance of enabling people to live well with the condition

- PMLiVE

NHS goes global with ‘Missing Type’ blood donor campaign

High profile brand partnership has already involved the likes of Microsoft, Waterstones and the RAF

- PMLiVE

Portrait exhibition raises refugee healthcare profile

Doctors of the World opens gallery to mark 10-year anniversary of its London clinic

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links